Virus Antibody Testing San Diego Ca
Lab Reagents
Human IgG antibody Laboratories manufactures the virus antibody testing san diego ca reagents distributed by Genprice. The Virus Antibody Testing San Diego Ca reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact virus Antibody. Other Virus products are available in stock. Specificity: Virus Category: Antibody Group: Testing San
Solute Carrier Family 4 Member 1 (Diego Blood Group) (SLC4A1) Antibody |
|||
20-abx115706 | Abbexa |
|
|
Solute Carrier Family 4 Member 1 (Diego Blood Group) (SLC4A1) Antibody |
|||
20-abx339200 | Abbexa |
|
|
Solute Carrier Family 4 Member 1 (Diego Blood Group) (SLC4A1) Antibody |
|||
20-abx339398 | Abbexa |
|
|
Solute Carrier Family 4 Member 1 (Diego Blood Group) (SLC4A1) Antibody |
|||
abx218630-100ug | Abbexa | 100 ug | EUR 439 |
CA-1001 |
|||
B2669-25 | Biovision | 25mg | EUR 591 |
CA-1001 |
|||
B2669-5 | Biovision | 5mg | EUR 186 |
CA-074 |
|||
B2971-1 | Biovision | 1 mg | EUR 196 |
CA-074 |
|||
B2971-5 | Biovision | 5 mg | EUR 637 |
AN3 CA |
|||
C0026002 | Addexbio | One Frozen vial | EUR 543 |
CA-5f |
|||
HY-112698 | MedChemExpress | 5mg | EUR 176 |
CA-074 |
|||
HY-103350 | MedChemExpress | 10mg | EUR 587 |
CA 074 |
|||
A1926-1 | ApexBio | 1 mg | EUR 148 |
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
CA 074 |
|||
A1926-10 | ApexBio | 10 mg | EUR 485 |
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
CA 074 |
|||
A1926-25 | ApexBio | 25 mg | EUR 746 |
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
CA 074 |
|||
A1926-5 | ApexBio | 5 mg | EUR 311 |
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
CA 074 |
|||
A1926-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 432 |
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
CA 074 |
|||
A1926-S | ApexBio | Evaluation Sample | EUR 81 |
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |